HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Viatris Wants To Free Men From Erectile Dysfunction Worries With UK Viagra Campaign

Executive Summary

Erectile dysfunction can happen to any adult male, but not to worry, help is available. This is the message of Viatris' new multi-million pound UK marketing campaign for Viagra Connect.

You may also be interested in...



Viatris Offers Viagra Connect In Smaller Trial Pack For UK Men

Viartris hopes its Viagra Connect two-pack will encourage British men to seek treatment for erectile dysfunction. 

Viagra Connect To Launch In Ireland Following Rx-to-OTC Switch

Viagra will soon be available OTC in Ireland following a successful switch, but patients will have to complete a mandatory consultation with a pharmacist before the ED treatment can be supplied.

Pfizer's Upjohn Breaking The Silence Around ED With New Viagra Connect Campaign In UK

Pfizer is investing roughly $10m in Viagra Connect in the UK to help raise awareness of erectile problems among the country's male population. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel